Found 0 matching trials
A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease PHASE3 The main purpose of this study is to look at how efgartigimod affects thyro...
Show More Location
Diabetes Associates Medical Group
Learn More & Join Trial
A Study of Efgartigimod IV in Participants From 12 Years to Less Than 18 Years of Age With Chronic Immune Thrombocytopenia (ITP) PHASE2 The main purpose of this study is to confirm the correct dose of efgartigim...
Show More Location
Centre Hospitalier Universitaire de Bordeaux Groupe Hospitalier Pellegrin Hopital des Enfants
Learn More & Join Trial
Efgartigimod for the Treatment of Acute Optic Neuritis PHASE2 The goal of this pilot clinical trial is to test efgartigimod alfa against ...
Show More Location
Massachusetts Eye and Ear Infirmary
Learn More & Join Trial
A Study to Evaluate the Efficacy and Safety of Efgartigimod PH20 Subcutaneous in Adult Patients With Primary Immune Thrombocytopenia PHASE3 This is a phase 3, multicenter, randomized, double-blinded, placebo-control...
Show More Location
Investigator Site 0010116
Learn More & Join Trial
Efgartigimod for the Treatment of Guillain-Barré Syndrome PHASE2 The goal of this clinical trial is to evaluating the efficacy and safety of...
Show More Location
Multiple Locations
Learn More & Join Trial
Seronegative Myasthenia Gravis - Efgartigimod IV PHASE3 This is to study the efficacy, safety and tolerability of efgartigimod in p...
Show More Location
University Health Network, Division of Neurology, Toronto General Hospital
Learn More & Join Trial
ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis N/A ADAPT Forward is a platform study with the aim to look at how safe differen...
Show More Location
Profound Research LLC - Carlsbad
Learn More & Join Trial
Evaluating the Pharmacodynamic Noninferiority of Efgartigimod PH20 SC Administered Subcutaneously as Compared to Efgartigimod Administered Intravenously in Patients With Generalized Myasthenia Gravis PHASE3 The purpose of this study is to investigate the Pharmacodynamics (PD), Phar...
Show More Location
Investigator site 2 - US0010032
Learn More & Join Trial
A Phase 3 Study to Evaluate the Safety and Efficacy of Efgartigimod PH20 Subcutaneous in Adult Patients With Primary Immune Thrombocytopenia PHASE3 A Phase 3 study to evaluate the safety and efficacy of efgartigimod PH20 su...
Show More Status
Active Not Recruiting
Location
Investigator Site 0010116
Learn More & Join Trial
Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis PHASE3 The purpose of this study is to assess how well nipocalimab works when comp...
Show More Location
Neurology Center of North Orange County
Learn More & Join Trial